The insulin-like growth factor axis and plasma lipid levels in the elderly

被引:56
作者
Ceda, GP
Dall'aglio, E
Magnacavallo, A
Vargas, N
Fontana, V
Maggio, M
Valenti, G
Lee, PDK
Hintz, RL
Hoffman, AR
机构
[1] Univ Parma, Cattedra Geriatr, I-43100 Parma, Italy
[2] Univ Parma, Cattedra Sci Alimentaz, I-43100 Parma, Italy
[3] Diagnost Syst Labs Inc, Webster, TX 77598 USA
[4] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[6] Vet Adm Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA
关键词
D O I
10.1210/jc.83.2.499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The activity of the hypothalamic-GH-insulin-like growth factor (IGF) network. declines with age. It has recently been shown that increased cardiovascular mortality occurs in adults with GH deficiency. As hypercholesterolemia is common in GH-deficient adults, and because there is experimental evidence that GH may play a role in regulating plasma cholesterol, we decided to investigate the activity of the GH-IGF axis in an elderly population by measuring serum IGF-I, IGF-LI, and IGF-binding protein-3 (IGFBP-3) levels and to study their relationship with blood lipid levels. One hundred and thirty-two elderly subjects, 52 men and 80 women, were studied (age range, 60-91 yr). Men had significantly lower levels of IGFBP-3, high density lipoprotein cholesterol (HDL-C) and apoprotein Al (ApoAl) compared to the women, whereas IGF-I and IGF-II were only slightly lower. Using Linear regression analysis, we observed an inverse relationship of age with IGF-I (r = -0.35; P < 0.001), IGF-II (r = 0.40; P < 0.001), IGFBP-3 (r = 0.52; P < 0.001), body mass index, and lipid levels. Univariate regression analysis showed a strong and positive correlation of both IGF-I and IGFBP-3 with HDL-C and ApoAl. Partial correlation analysis, after adjustment for age and body mass index, showed that IGFBP-3 and IGF-II were still significantly and positively related to HDL-C and ApoAl. Furthermore, a strong association was documented among IGF-I, IGF-II, and IGFBP-3. These data demonstrate that even in an elderly population, further aging is accompanied by a progressive decline in circulating IGF-I, IGF-II, and IGFBP-3, suggesting a continuing diminution of the GH-IGF axis throughout aging. Moreover, the strong correlation between HDL-C and an index of GH secretion, such as IGFBP-3, suggests that GH might play an important role in lipid metabolism in healthy elderly subjects.
引用
收藏
页码:499 / 502
页数:4
相关论文
共 38 条
[1]   LOW CIRCULATING LEVELS OF INSULIN-LIKE GROWTH-FACTORS AND TESTOSTERONE IN CHRONICALLY INSTITUTIONALIZED ELDERLY MEN [J].
ABBASI, AA ;
DRINKA, PJ ;
MATTSON, DE ;
RUDMAN, D .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1993, 41 (09) :975-982
[2]   THE EFFECTS OF SHORT AND LONG-TERM GROWTH-HORMONE REPLACEMENT THERAPY IN HYPOPITUITARY ADULTS ON LIPID-METABOLISM AND CARBOHYDRATE-TOLERANCE [J].
BESHYAH, SA ;
HENDERSON, A ;
NITHTHYANANTHAN, R ;
SKINNER, E ;
ANYAOKU, V ;
RICHMOND, W ;
SHARP, P ;
JOHNSTON, DG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02) :356-363
[3]   THE EFFECT OF GROWTH-HORMONE ADMINISTRATION IN GROWTH-HORMONE DEFICIENT ADULTS ON BONE, PROTEIN, CARBOHYDRATE AND LIPID HOMEOSTASIS, AS WELL AS ON BODY-COMPOSITION [J].
BINNERTS, A ;
SWART, GR ;
WILSON, JHP ;
HOOGERBRUGGE, N ;
POLS, HAP ;
BIRKENHAGER, JC ;
LAMBERTS, SWJ .
CLINICAL ENDOCRINOLOGY, 1992, 37 (01) :79-87
[4]   GROWTH-HORMONE IN THE REGULATION OF HYPERLIPIDEMIA [J].
BLACKETT, PR ;
WEECH, PK ;
MCCONATHY, WJ ;
FESMIRE, JD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (02) :117-120
[5]   THE EFFECTS OF AGING ON THE SECRETION OF THE COMMON ALPHA-SUBUNIT OF THE GLYCOPROTEIN HORMONES IN MEN [J].
CEDA, GP ;
DENTI, L ;
CERESINI, G ;
TORSIGLIERI, W ;
HOFFMAN, AR ;
VALENTI, G .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (04) :353-358
[6]   HUMAN GROWTH-HORMONE AND HUMAN AGING [J].
CORPAS, E ;
HARMAN, SM ;
BLACKMAN, MR .
ENDOCRINE REVIEWS, 1993, 14 (01) :20-39
[7]   GROWTH-HORMONE TREATMENT IMPROVES SERUM-LIPIDS AND LIPOPROTEINS IN ADULTS WITH GROWTH-HORMONE DEFICIENCY [J].
CUNEO, RC ;
SALOMON, F ;
WATTS, GF ;
HESP, R ;
SONKSEN, PH .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (12) :1519-1523
[8]   SERUM-LIPID LEVELS IN GROWTH HORMONE-DEFICIENT MEN [J].
DEBOER, H ;
BLOK, GJ ;
VOERMAN, HJ ;
PHILLIPS, M ;
SCHOUTEN, JA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (02) :199-203
[9]   GROWTH-HORMONE TREATMENT OF GROWTH HORMONE-DEFICIENT ADULTS RESULTS IN A MARKED INCREASE IN LP(A) AND HDL CHOLESTEROL CONCENTRATIONS [J].
EDEN, S ;
WIKLUND, O ;
OSCARSSON, J ;
ROSEN, T ;
BENGTSSON, BA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02) :296-301
[10]   INVIVO GROWTH-HORMONE TREATMENT STIMULATES SECRETION OF VERY LOW-DENSITY-LIPOPROTEIN BY THE ISOLATED PERFUSED-RAT-LIVER [J].
ELAM, MB ;
WILCOX, HG ;
SOLOMON, SS ;
HEIMBERG, M .
ENDOCRINOLOGY, 1992, 131 (06) :2717-2722